Application Nr Approved Date Route Status External Links
NDA021205 2000-11-14 Oral RX Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Trizivir Is Indicated In Combination With Other Antiretrovirals Or Alone For The Treatment Of Human Immunodeficiency Virus Type 1 (hiv‑1) Infection. Limitations Of Use: •limited Data Exist On The Use Of Trizivir Alone In Patients With Higher Baseline Viral Load Levels (greater Than 100,000 Copies Per Ml) [see Clinical Studies (14)]. Trizivir, A Combination Of Abacavir, Lamivudine, And Zidovudine, Each Nucleoside Analogue Hiv-1 Reverse Transcriptase Inhibitors, Is Indicated In Combination With Other Antiretroviral Agents For The Treatment Of Hiv‑1 Infection. (1)

All Formulated Excipients (2 Total)

Name Structure Kind Function Status
1. Magnesium Stearate MAGNESIUM STEARATE Molecular AF-Antifoaming (or defoaming) agent , MISC-Miscellaneous REG-Food additives for which a petition has been filed and a regulation issued.
2. Cellulose, Microcrystalline CELLULOSE, MICROCRYSTALLINE Unresolved

Active Ingredients ( 3 Total)

Comments